About: This sample creates three simple types of notifications:
A phone-only notification
A watch-only notification
A pair of synchronized phone and watch notifications where the content shown
on the watch notification is different from the one on the phone. These notifications
are synchronized in the sense that dismissing one results in dismissal of the other one
(all based on the Data Layer APIs).
How to run: Install the Application APK on the companion, and the Wearable APK on the
wearable. Start the sample by running the SynchronizedNotifications application on the companion.


About me
I am actively trying to get better with React/Vue/Angular and this whole 'front end' craze. I'm not a super creative person when it comes to UI looks, but I enjoy creating something usable and nice looking from front to back.
I am most comfortable with full stack applications, primarily used with backend web frameworks such as Java and J2EE based frameworks. I worked heavily in the backend, and infrastructure portion of many of my jobs and projects. That means I also mess around with Jenkins, CI/CD, google cloud and all that fun jazz.
I worked in a full-time position as software engineer on a large scale web application using JavaScript and Java to help thousands of customers to introduce a feedback culture in their companies. Those years gave me a lot of practical experiences in the field and I tried to convey a part of the information on my blog. But I am always keen to learn something new, so I try to push myself every day.
I try my best to have a positive impact on the world. 99% of my code is open source for everyone on GitHub. Every time I build a product/service for myself, I immediately think about how to open source it for others. Even though I open source my work and offer lots of learning material for free, not everyone is able to make use of it.
Outside of the office I like to keep active, taking part in a multitude of activities and have a strong passion for travelling.
By Arul
UI Developer
Glasgow
Glasgow


This week I worked on adding new features to a new system known as the (MCRLTR) - Its meant to be used by scientists to report certain information after an experiment has been carried out.
This application is written in ASP.NET and C#. The information that are added requires being saved on a Sharepoint List.
This week I also worked on existing system. I made some changes on the main sign-up page of our systems (AUTH program we call it), adding "terms and conditions" based on certain user-selection.
Listed below are the key things I was involved with doing this week..
- MCRLTR (New Application) Demo To User
- Had a 2 hours meeting with a user to show him the progress we've made with the new web application we're building for him and his team.
He appreciated the system but also made a lot of feature requests (some of which were part of the initial requirements of the application anyway).
- Computing Group Meeting (Computing in CLF - Making Simulations)
- We had a computing group meeting this week and had a talk that was given by someone from another department of STFC - CLF (Central Laser Facility). His talk was basically about the impact of computing on Laser Experiments, specifically in regards to making simulations.
- Worked On Email Templates Getting Sent to users - (Using FreeMarker)
- This week I also worked on the email templates that is being used by one of our systems to send rather important emails out to users of the software and facility. This got me to investigate the use of FreeMarker to customise emails and adjust parts of an email dynamically!
- Watched a 2 hours VIDEO TUTORIAL on LESS and SASS
- Yeah, learnt and had an amazing realisation of how you can do a lot more with CSS using "LESS" or "SASS". Emphasis on the tutorial was on when CSS is Painful on its own, why "LESS" is More, and then using "SASS" - which in my opinion is "LESS" with extras..
This Tutorial was in preparation for a project that the team will be embarking on which the team is looking to use "LESS".
- Watched a 3 hours VIDEO TUTORIAL on AngularJS
- Learnt about ANgularJS - The tutorial used an on-line tool to write code which I thought was incredibly useful (Plunker)
Learnt about IIFE in Javascript, and then a deeper dive into AngularJS Controllers, Directives & Views, Services and Routing.
I at the end of the tutorial realised a lot more can be achieved on the client-side of a web application using AngularJS.
- Watched a 1 hour VIDEO TUTORIAL on SQL
- This was specifically on using "JOIN" in SQl which is also incredibly useful for querying multiple database tables
Listed below are the key things I was involved with doing this week..
- Supporter of the week
- I was the supporter of the week this week, and I was therefore responsible for helping out the users of our software if/when a big issue arises. I was also documenting reports and bugs by creating tickets for them.
- 3 Hours Training Meeting With A User
- I visited a user to train her on using the new (Scheduler) software that had only be released for full use a month before. The meeting was although long but very productive in that it resulted in bug discoveries while I was still with the user and also feature requests from the user. My presence was an opportunity to reassure the user that although there are still issues here and there with the system because its still new, there aren't show-stoppers and the system can actually be trusted especially as other users are currently using the software successfully.
- Had a 1 Hour Meeting With Some Users About How To WorK-Around A Certain Issue on A system till a more appropriate way is found
- Added more features To the new MCRLTR
- STEM Networking Sessions
- I attended a STEM Ambassador Networking session which was mainly setup with the aim of discussing ideas for activities and training
- Had a 1 Hour Meeting With Some Users About How To WorK-Around A Certain Issue on A system till a more appropriate way is found
- Attending A Talk On "Energy for the 21st Century" by Professor Roger Cashmore CMG, FRS - Chairman, United Kingdom Atomic Energy Authority
- As part of the opportunities of being at a place like STFC is the amount of talks that are help on-site, talks that can be freely attended.
I attended a talk that covered the current sources of energy particularly in the UK and the way to go in terms of considering the future (which the speaker placed emphasis on the need for investment into Nuclear power), there are of-course challenges!
- Huge Performance Upgrade on The New MCRLTR Application - Using A Tree Data Structure
- I made a huge performance upgrade on a part of the MCRLTR application that was supposed to allow a user to select a Parent Category, and then based on that select the appropriate Child Category, and then based on then select a Grand-Child Category, and then a Great-Grand Child Category. This information being read is from a sharepoint which I had previously structured in a way for each element to know of its parent or children. Previously, the system was build in a way where a Parent Category is generated and then upon selection by a user a web service call to the Sharepoint list will be made in order to retrieve the Children.... This made this process incredibly slow for proper usage especially because the application will be expected to be used on mobile devices like the Ipad...
To improve this, the first idea was to build the entire list of categories locally into a Tree Structure (thanks to ONE web-service call), and then transverse through this list locally to get data and build Children Categories (this, in place of making web-service calls to sharepoint every time a new Category list needs to be built.)


Address
Delhi Road
Saharanpur
Uttar Pradesh
Phone
123-456-78901548
<EMAIL_ADDRESS>Have a question or want further information?
Fill in the short form and we will get back to you as soon as possible.
Delhi Road
Saharanpur
Uttar Pradesh
123-456-78901548
vrindasinghal196@gmail.com


public
static
Collection fields.
Even though they are often used to store collections of constant values, these fields nonetheless represent a security
hazard, as their contents may be modified even if the field is declared as final
.
Example:
public static final List<String> EVENTS = new ArrayList<>();
Use the table in the Options section to specify methods returning unmodifiable collections.
public
static
collection fields initialized with these methods will not be reported.


The open cell voltage refers to the sitting or unloaded voltage of a battery. In other words, the open cell voltage would be the voltage of a battery when no current is going in or out of the battery. This is important for determining how much current can go in or out of the battery.
| < On-Board Diagnostics II (OBD2) | Plugin Hybrid Electric Vehicle (PHEV) > |


Settings 1
Settings 2
Settings 3
Sorry!
Kubevious works with Desktop browsers only.
See Demo in Youtube


Questions with a link to this one.
Options
Text
Outcome type
Question
Text
Remove
Remove
Add question outcome
Add text outcome
You must save and link this question to another in order to add options.
Save


Request a Quote
Request a Quote
Provide the information below and we will reach out to provide a price quote for your move.
Name
First
Last
Phone
(###) ### ####
Email
Pick Up Address
Street Address
Address Line 2
City
State / Province / Region
Postal / Zip Code
United States
Canada
Mexico
Country
Drop Off Address
Street Address
Address Line 2
City
State / Province / Region
Postal / Zip Code
United States
Canada
Mexico
Country
Moving Date
/
MM
/
DD
YYYY
Special Considerations / Comments


Fill out the online form to tell us about your professional experience in human/animal health, epidemiology, infectious disease or related fields.
Our quick, informative online training will provide you with everything you need to know in order to become a certified EpiCore member.
Respond to requests for information on the EpiCore platform regarding disease outbreaks in your region. Just a few minutes could be all it takes to save a life.


‘Don’t talk. I want to hear what hapens.’
‘Is samething happening?’ I inquired innocently.
‘You mean to say you don’t know?’ said Miss Baker, hon-estly surprised.
‘I thought everybody knew.’
‘I don’t.’
‘Why——’ she said hesitantly,
‘Tom’s got some woman in New York.’


| MPCD |
DMARD |
Cancer |
Hematologic Cancer |
420 |
0 |
322.3929 |
100 |
0 |
| MPCD |
DMARD |
Cancer |
Non Melanoma Skin Cancer |
420 |
2 |
323.499 |
100 |
0.61824 |
| MPCD |
DMARD |
Cancer |
Solid Cancer |
420 |
10 |
312.2628 |
100 |
3.20243 |
| MPCD |
DMARD |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
420 |
1 |
325.974 |
100 |
0.306773 |
| MPCD |
DMARD |
Cardiac disease |
Conduction Block |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Cardiac disease |
Myocardial infarction |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Infection |
Hospitalized infection |
420 |
4 |
321.399 |
100 |
1.244559 |
| MPCD |
DMARD |
Infection |
Opportunistic infection |
420 |
3 |
321.0212 |
100 |
0.934518 |
| MPCD |
DMARD |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
420 |
6 |
320.2546 |
100 |
1.873509 |
| MPCD |
DMARD |
Kidney disease |
Amyloidosis |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Kidney disease |
IgA nephropathy |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Kidney disease |
Nephrotic syndrome |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Lung disease |
Apical Pulmonary fibrosis |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Lung disease |
Interstitial lung disease |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Lung disease |
Restrictive lung disease |
420 |
0 |
325.1034 |
100 |
0 |
| MPCD |
DMARD |
Neurological Disease |
Cauda Equina syndrome |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Neurological Disease |
Spinal Cord compression |
420 |
0 |
326.5325 |
100 |
0 |
| MPCD |
DMARD |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
420 |
5 |
317.9055 |
100 |
1.572794 |
| MPCD |
DMARD |
PsO/PsA |
Psoriasis or psoriatic arthritis |
420 |
16 |
310.3354 |
100 |
5.155712 |
| MPCD |
DMARD |
Uveitis |
Uveitis |
420 |
10 |
311.1869 |
100 |
3.213503 |
| MPCD |
NSAID |
Cancer |
Hematologic Cancer |
578 |
1 |
419.4743 |
100 |
0.238394 |
| MPCD |
NSAID |
Cancer |
Non Melanoma Skin Cancer |
578 |
1 |
420.3149 |
100 |
0.237917 |
| MPCD |
NSAID |
Cancer |
Solid Cancer |
578 |
8 |
411.3566 |
100 |
1.944785 |
| MPCD |
NSAID |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
578 |
2 |
416.553 |
100 |
0.480131 |
| MPCD |
NSAID |
Cardiac disease |
Conduction Block |
578 |
2 |
418.2259 |
100 |
0.47821 |
| MPCD |
NSAID |
Cardiac disease |
Myocardial infarction |
578 |
0 |
421.0897 |
100 |
0 |
| MPCD |
NSAID |
Infection |
Hospitalized infection |
578 |
4 |
416.4983 |
100 |
0.960388 |
| MPCD |
NSAID |
Infection |
Opportunistic infection |
578 |
1 |
418.1629 |
100 |
0.239141 |
| MPCD |
NSAID |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
578 |
5 |
416.5147 |
100 |
1.200438 |
| MPCD |
NSAID |
Kidney disease |
Amyloidosis |
578 |
0 |
421.0897 |
100 |
0 |
| MPCD |
NSAID |
Kidney disease |
IgA nephropathy |
578 |
1 |
420.7228 |
100 |
0.237686 |
| MPCD |
NSAID |
Kidney disease |
Nephrotic syndrome |
578 |
0 |
421.0897 |
100 |
0 |
| MPCD |
NSAID |
Lung disease |
Apical Pulmonary fibrosis |
578 |
0 |
421.0897 |
100 |
0 |
| MPCD |
NSAID |
Lung disease |
Interstitial lung disease |
578 |
0 |
421.0897 |
100 |
0 |
| MPCD |
NSAID |
Lung disease |
Restrictive lung disease |
578 |
5 |
416.1588 |
100 |
1.201464 |
| MPCD |
NSAID |
Neurological Disease |
Cauda Equina syndrome |
578 |
0 |
421.0897 |
100 |
0 |
| MPCD |
NSAID |
Neurological Disease |
Spinal Cord compression |
578 |
1 |
420.104 |
100 |
0.238036 |
| MPCD |
NSAID |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
578 |
6 |
414.3409 |
100 |
1.448083 |
| MPCD |
NSAID |
PsO/PsA |
Psoriasis or psoriatic arthritis |
578 |
8 |
409.1663 |
100 |
1.955195 |
| MPCD |
NSAID |
Uveitis |
Uveitis |
578 |
7 |
414.8255 |
100 |
1.687457 |
| MPCD |
No exposure |
Cancer |
Hematologic Cancer |
1307 |
11 |
1593.788 |
100 |
0.69018 |
| MPCD |
No exposure |
Cancer |
Non Melanoma Skin Cancer |
1307 |
25 |
1569.27 |
100 |
1.593097 |
| MPCD |
No exposure |
Cancer |
Solid Cancer |
1307 |
82 |
1502.201 |
100 |
5.458656 |
| MPCD |
No exposure |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
1307 |
29 |
1563.732 |
100 |
1.854538 |
| MPCD |
No exposure |
Cardiac disease |
Conduction Block |
1307 |
18 |
1585.566 |
100 |
1.135241 |
| MPCD |
No exposure |
Cardiac disease |
Myocardial infarction |
1307 |
3 |
1599.269 |
100 |
0.187586 |
| MPCD |
No exposure |
Infection |
Hospitalized infection |
1307 |
69 |
1528.487 |
100 |
4.514267 |
| MPCD |
No exposure |
Infection |
Opportunistic infection |
1307 |
10 |
1593.487 |
100 |
0.627555 |
| MPCD |
No exposure |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
1307 |
50 |
1554.639 |
100 |
3.21618 |
| MPCD |
No exposure |
Kidney disease |
Amyloidosis |
1307 |
3 |
1602.79 |
100 |
0.187174 |
| MPCD |
No exposure |
Kidney disease |
IgA nephropathy |
1307 |
1 |
1602.396 |
100 |
0.062407 |
| MPCD |
No exposure |
Kidney disease |
Nephrotic syndrome |
1307 |
0 |
1603.992 |
100 |
0 |
| MPCD |
No exposure |
Lung disease |
Apical Pulmonary fibrosis |
1307 |
1 |
1603.272 |
100 |
0.062372 |
| MPCD |
No exposure |
Lung disease |
Interstitial lung disease |
1307 |
0 |
1603.992 |
100 |
0 |
| MPCD |
No exposure |
Lung disease |
Restrictive lung disease |
1307 |
16 |
1592.862 |
100 |
1.004481 |
| MPCD |
No exposure |
Neurological Disease |
Cauda Equina syndrome |
1307 |
1 |
1603.403 |
100 |
0.062367 |
| MPCD |
No exposure |
Neurological Disease |
Spinal Cord compression |
1307 |
2 |
1603.863 |
100 |
0.124699 |
| MPCD |
No exposure |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
1307 |
62 |
1539.691 |
100 |
4.026783 |
| MPCD |
No exposure |
PsO/PsA |
Psoriasis or psoriatic arthritis |
1307 |
62 |
1533.309 |
100 |
4.043543 |
| MPCD |
No exposure |
Uveitis |
Uveitis |
1307 |
61 |
1533.689 |
100 |
3.977338 |
| MPCD |
TNF |
Cancer |
Hematologic Cancer |
994 |
2 |
1096.454 |
100 |
0.182406 |
| MPCD |
TNF |
Cancer |
Non Melanoma Skin Cancer |
994 |
12 |
1085.153 |
100 |
1.105835 |
| MPCD |
TNF |
Cancer |
Solid Cancer |
994 |
16 |
1075.17 |
100 |
1.488136 |
| MPCD |
TNF |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
994 |
9 |
1089.506 |
100 |
0.826063 |
| MPCD |
TNF |
Cardiac disease |
Conduction Block |
994 |
2 |
1096.454 |
100 |
0.182406 |
| MPCD |
TNF |
Cardiac disease |
Myocardial infarction |
994 |
1 |
1095.466 |
100 |
0.091285 |
| MPCD |
TNF |
Infection |
Hospitalized infection |
994 |
23 |
1076.841 |
100 |
2.135878 |
| MPCD |
TNF |
Infection |
Opportunistic infection |
994 |
13 |
1080.66 |
100 |
1.202969 |
| MPCD |
TNF |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
994 |
63 |
1016.676 |
100 |
6.196663 |
| MPCD |
TNF |
Kidney disease |
Amyloidosis |
994 |
1 |
1097.719 |
100 |
0.091098 |
| MPCD |
TNF |
Kidney disease |
IgA nephropathy |
994 |
3 |
1094.858 |
100 |
0.274008 |
| MPCD |
TNF |
Kidney disease |
Nephrotic syndrome |
994 |
2 |
1095.255 |
100 |
0.182606 |
| MPCD |
TNF |
Lung disease |
Apical Pulmonary fibrosis |
994 |
0 |
1098.218 |
100 |
0 |
| MPCD |
TNF |
Lung disease |
Interstitial lung disease |
994 |
0 |
1098.218 |
100 |
0 |
| MPCD |
TNF |
Lung disease |
Restrictive lung disease |
994 |
4 |
1092.361 |
100 |
0.366179 |
| MPCD |
TNF |
Neurological Disease |
Cauda Equina syndrome |
994 |
0 |
1098.218 |
100 |
0 |
| MPCD |
TNF |
Neurological Disease |
Spinal Cord compression |
994 |
0 |
1098.218 |
100 |
0 |
| MPCD |
TNF |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
994 |
17 |
1079.324 |
100 |
1.57506 |
| MPCD |
TNF |
PsO/PsA |
Psoriasis or psoriatic arthritis |
994 |
67 |
1004.252 |
100 |
6.671633 |
| MPCD |
TNF |
Uveitis |
Uveitis |
994 |
38 |
1032.287 |
100 |
3.681145 |
| Marketscan |
DMARD |
Cancer |
Hematologic Cancer |
1661 |
5 |
1307.326 |
100 |
0.38246 |
| Marketscan |
DMARD |
Cancer |
Non Melanoma Skin Cancer |
1661 |
6 |
1310.839 |
100 |
0.457722 |
| Marketscan |
DMARD |
Cancer |
Solid Cancer |
1661 |
36 |
1271.302 |
100 |
2.831743 |
| Marketscan |
DMARD |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
1661 |
4 |
1313.607 |
100 |
0.304505 |
| Marketscan |
DMARD |
Cardiac disease |
Conduction Block |
1661 |
4 |
1313.413 |
100 |
0.30455 |
| Marketscan |
DMARD |
Cardiac disease |
Myocardial infarction |
1661 |
1 |
1318.404 |
100 |
0.075849 |
| Marketscan |
DMARD |
Infection |
Hospitalized infection |
1661 |
33 |
1287.77 |
100 |
2.562569 |
| Marketscan |
DMARD |
Infection |
Opportunistic infection |
1661 |
9 |
1312.46 |
100 |
0.685735 |
| Marketscan |
DMARD |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
1661 |
38 |
1264.693 |
100 |
3.004683 |
| Marketscan |
DMARD |
Kidney disease |
Amyloidosis |
1661 |
0 |
1320.022 |
100 |
0 |
| Marketscan |
DMARD |
Kidney disease |
IgA nephropathy |
1661 |
0 |
1320.022 |
100 |
0 |
| Marketscan |
DMARD |
Kidney disease |
Nephrotic syndrome |
1661 |
0 |
1320.022 |
100 |
0 |
| Marketscan |
DMARD |
Lung disease |
Apical Pulmonary fibrosis |
1661 |
0 |
1320.022 |
100 |
0 |
| Marketscan |
DMARD |
Lung disease |
Interstitial lung disease |
1661 |
0 |
1320.022 |
100 |
0 |
| Marketscan |
DMARD |
Lung disease |
Restrictive lung disease |
1661 |
2 |
1310.549 |
100 |
0.152608 |
| Marketscan |
DMARD |
Neurological Disease |
Cauda Equina syndrome |
1661 |
0 |
1320.022 |
100 |
0 |
| Marketscan |
DMARD |
Neurological Disease |
Spinal Cord compression |
1661 |
0 |
1320.022 |
100 |
0 |
| Marketscan |
DMARD |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
1661 |
13 |
1303.786 |
100 |
0.997096 |
| Marketscan |
DMARD |
PsO/PsA |
Psoriasis or psoriatic arthritis |
1661 |
98 |
1229.689 |
100 |
7.969493 |
| Marketscan |
DMARD |
Uveitis |
Uveitis |
1661 |
38 |
1268.739 |
100 |
2.995099 |
| Marketscan |
NSAID |
Cancer |
Hematologic Cancer |
2890 |
7 |
2223.978 |
100 |
0.314751 |
| Marketscan |
NSAID |
Cancer |
Non Melanoma Skin Cancer |
2890 |
3 |
2227.039 |
100 |
0.134708 |
| Marketscan |
NSAID |
Cancer |
Solid Cancer |
2890 |
37 |
2155.948 |
100 |
1.716182 |
| Marketscan |
NSAID |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
2890 |
12 |
2210.798 |
100 |
0.54279 |
| Marketscan |
NSAID |
Cardiac disease |
Conduction Block |
2890 |
13 |
2205.933 |
100 |
0.58932 |
| Marketscan |
NSAID |
Cardiac disease |
Myocardial infarction |
2890 |
1 |
2225.322 |
100 |
0.044937 |
| Marketscan |
NSAID |
Infection |
Hospitalized infection |
2890 |
65 |
2174.984 |
100 |
2.988527 |
| Marketscan |
NSAID |
Infection |
Opportunistic infection |
2890 |
18 |
2204.827 |
100 |
0.816391 |
| Marketscan |
NSAID |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
2890 |
26 |
2168.712 |
100 |
1.198868 |
| Marketscan |
NSAID |
Kidney disease |
Amyloidosis |
2890 |
0 |
2228.241 |
100 |
0 |
| Marketscan |
NSAID |
Kidney disease |
IgA nephropathy |
2890 |
0 |
2228.241 |
100 |
0 |
| Marketscan |
NSAID |
Kidney disease |
Nephrotic syndrome |
2890 |
0 |
2228.241 |
100 |
0 |
| Marketscan |
NSAID |
Lung disease |
Apical Pulmonary fibrosis |
2890 |
0 |
2228.241 |
100 |
0 |
| Marketscan |
NSAID |
Lung disease |
Interstitial lung disease |
2890 |
0 |
2228.241 |
100 |
0 |
| Marketscan |
NSAID |
Lung disease |
Restrictive lung disease |
2890 |
9 |
2209.385 |
100 |
0.407353 |
| Marketscan |
NSAID |
Neurological Disease |
Cauda Equina syndrome |
2890 |
1 |
2227.989 |
100 |
0.044884 |
| Marketscan |
NSAID |
Neurological Disease |
Spinal Cord compression |
2890 |
2 |
2227.398 |
100 |
0.089791 |
| Marketscan |
NSAID |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
2890 |
30 |
2188.961 |
100 |
1.370513 |
| Marketscan |
NSAID |
PsO/PsA |
Psoriasis or psoriatic arthritis |
2890 |
34 |
2167.403 |
100 |
1.568698 |
| Marketscan |
NSAID |
Uveitis |
Uveitis |
2890 |
49 |
2152.003 |
100 |
2.276949 |
| Marketscan |
No exposure |
Cancer |
Hematologic Cancer |
3947 |
26 |
3848.09 |
100 |
0.67566 |
| Marketscan |
No exposure |
Cancer |
Non Melanoma Skin Cancer |
3947 |
42 |
3831.357 |
100 |
1.096217 |
| Marketscan |
No exposure |
Cancer |
Solid Cancer |
3947 |
138 |
3722.166 |
100 |
3.707519 |
| Marketscan |
No exposure |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
3947 |
46 |
3820.931 |
100 |
1.203895 |
| Marketscan |
No exposure |
Cardiac disease |
Conduction Block |
3947 |
50 |
3835.71 |
100 |
1.30354 |
| Marketscan |
No exposure |
Cardiac disease |
Myocardial infarction |
3947 |
15 |
3859.934 |
100 |
0.388608 |
| Marketscan |
No exposure |
Infection |
Hospitalized infection |
3947 |
197 |
3667.691 |
100 |
5.371227 |
| Marketscan |
No exposure |
Infection |
Opportunistic infection |
3947 |
45 |
3841.969 |
100 |
1.171275 |
| Marketscan |
No exposure |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
3947 |
212 |
3692.301 |
100 |
5.741677 |
| Marketscan |
No exposure |
Kidney disease |
Amyloidosis |
3947 |
0 |
3881.248 |
100 |
0 |
| Marketscan |
No exposure |
Kidney disease |
IgA nephropathy |
3947 |
4 |
3875.173 |
100 |
0.103221 |
| Marketscan |
No exposure |
Kidney disease |
Nephrotic syndrome |
3947 |
1 |
3880.438 |
100 |
0.02577 |
| Marketscan |
No exposure |
Lung disease |
Apical Pulmonary fibrosis |
3947 |
0 |
3881.248 |
100 |
0 |
| Marketscan |
No exposure |
Lung disease |
Interstitial lung disease |
3947 |
6 |
3872.194 |
100 |
0.154951 |
| Marketscan |
No exposure |
Lung disease |
Restrictive lung disease |
3947 |
41 |
3841.467 |
100 |
1.0673 |
| Marketscan |
No exposure |
Neurological Disease |
Cauda Equina syndrome |
3947 |
2 |
3879.97 |
100 |
0.051547 |
| Marketscan |
No exposure |
Neurological Disease |
Spinal Cord compression |
3947 |
2 |
3880.345 |
100 |
0.051542 |
| Marketscan |
No exposure |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
3947 |
82 |
3787.702 |
100 |
2.164901 |
| Marketscan |
No exposure |
PsO/PsA |
Psoriasis or psoriatic arthritis |
3947 |
184 |
3745.771 |
100 |
4.912206 |
| Marketscan |
No exposure |
Uveitis |
Uveitis |
3947 |
201 |
3687.91 |
100 |
5.450242 |
| Marketscan |
TNF |
Cancer |
Hematologic Cancer |
4768 |
7 |
5445.306 |
100 |
0.128551 |
| Marketscan |
TNF |
Cancer |
Non Melanoma Skin Cancer |
4768 |
33 |
5401.574 |
100 |
0.610933 |
| Marketscan |
TNF |
Cancer |
Solid Cancer |
4768 |
70 |
5342.062 |
100 |
1.310356 |
| Marketscan |
TNF |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
4768 |
30 |
5399.904 |
100 |
0.555565 |
| Marketscan |
TNF |
Cardiac disease |
Conduction Block |
4768 |
20 |
5420.296 |
100 |
0.368984 |
| Marketscan |
TNF |
Cardiac disease |
Myocardial infarction |
4768 |
6 |
5450.557 |
100 |
0.11008 |
| Marketscan |
TNF |
Infection |
Hospitalized infection |
4768 |
227 |
5217.684 |
100 |
4.350589 |
| Marketscan |
TNF |
Infection |
Opportunistic infection |
4768 |
55 |
5390.897 |
100 |
1.020238 |
| Marketscan |
TNF |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
4768 |
255 |
5085.525 |
100 |
5.014232 |
| Marketscan |
TNF |
Kidney disease |
Amyloidosis |
4768 |
2 |
5452.561 |
100 |
0.03668 |
| Marketscan |
TNF |
Kidney disease |
IgA nephropathy |
4768 |
4 |
5449.766 |
100 |
0.073398 |
| Marketscan |
TNF |
Kidney disease |
Nephrotic syndrome |
4768 |
1 |
5449.615 |
100 |
0.01835 |
| Marketscan |
TNF |
Lung disease |
Apical Pulmonary fibrosis |
4768 |
0 |
5453.5 |
100 |
0 |
| Marketscan |
TNF |
Lung disease |
Interstitial lung disease |
4768 |
4 |
5450.921 |
100 |
0.073382 |
| Marketscan |
TNF |
Lung disease |
Restrictive lung disease |
4768 |
27 |
5419.682 |
100 |
0.498184 |
| Marketscan |
TNF |
Neurological Disease |
Cauda Equina syndrome |
4768 |
1 |
5450.716 |
100 |
0.018346 |
| Marketscan |
TNF |
Neurological Disease |
Spinal Cord compression |
4768 |
9 |
5443.636 |
100 |
0.165331 |
| Marketscan |
TNF |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
4768 |
54 |
5375.767 |
100 |
1.004508 |
| Marketscan |
TNF |
PsO/PsA |
Psoriasis or psoriatic arthritis |
4768 |
341 |
4993.421 |
100 |
6.828986 |
| Marketscan |
TNF |
Uveitis |
Uveitis |
4768 |
205 |
5117.41 |
100 |
4.005933 |
| Medicare |
DMARD |
Cancer |
Hematologic Cancer |
3824 |
21 |
8345.741 |
100 |
0.251625 |
| Medicare |
DMARD |
Cancer |
Non Melanoma Skin Cancer |
3824 |
58 |
8272.189 |
100 |
0.701145 |
| Medicare |
DMARD |
Cancer |
Solid Cancer |
3824 |
160 |
7677.596 |
100 |
2.083986 |
| Medicare |
DMARD |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
3824 |
68 |
8148.255 |
100 |
0.834535 |
| Medicare |
DMARD |
Cardiac disease |
Conduction Block |
3824 |
60 |
8246.732 |
100 |
0.727561 |
| Medicare |
DMARD |
Cardiac disease |
Myocardial infarction |
3824 |
29 |
8393.112 |
100 |
0.345521 |
| Medicare |
DMARD |
Infection |
Hospitalized infection |
3824 |
352 |
7661.889 |
100 |
4.594167 |
| Medicare |
DMARD |
Infection |
Opportunistic infection |
3824 |
85 |
8124.189 |
100 |
1.046258 |
| Medicare |
DMARD |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
3824 |
100 |
7882.642 |
100 |
1.26861 |
| Medicare |
DMARD |
Kidney disease |
Amyloidosis |
3824 |
0 |
8470.204 |
100 |
0 |
| Medicare |
DMARD |
Kidney disease |
IgA nephropathy |
3824 |
4 |
8462.982 |
100 |
0.047265 |
| Medicare |
DMARD |
Kidney disease |
Nephrotic syndrome |
3824 |
1 |
8462.171 |
100 |
0.011817 |
| Medicare |
DMARD |
Lung disease |
Apical Pulmonary fibrosis |
3824 |
1 |
8470.642 |
100 |
0.011805 |
| Medicare |
DMARD |
Lung disease |
Interstitial lung disease |
3824 |
13 |
8400.074 |
100 |
0.154761 |
| Medicare |
DMARD |
Lung disease |
Restrictive lung disease |
3824 |
66 |
8191.737 |
100 |
0.80569 |
| Medicare |
DMARD |
Neurological Disease |
Cauda Equina syndrome |
3824 |
1 |
8471.893 |
100 |
0.011804 |
| Medicare |
DMARD |
Neurological Disease |
Spinal Cord compression |
3824 |
5 |
8453.525 |
100 |
0.059147 |
| Medicare |
DMARD |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
3824 |
68 |
8107.948 |
100 |
0.838683 |
| Medicare |
DMARD |
PsO/PsA |
Psoriasis or psoriatic arthritis |
3824 |
191 |
7726.434 |
100 |
2.472033 |
| Medicare |
DMARD |
Uveitis |
Uveitis |
3824 |
84 |
8069.161 |
100 |
1.041 |
| Medicare |
NSAID |
Cancer |
Hematologic Cancer |
8856 |
52 |
16086.29 |
100 |
0.323257 |
| Medicare |
NSAID |
Cancer |
Non Melanoma Skin Cancer |
8856 |
99 |
16054.74 |
100 |
0.616641 |
| Medicare |
NSAID |
Cancer |
Solid Cancer |
8856 |
262 |
14703.83 |
100 |
1.781848 |
| Medicare |
NSAID |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
8856 |
127 |
15505.97 |
100 |
0.819039 |
| Medicare |
NSAID |
Cardiac disease |
Conduction Block |
8856 |
101 |
15699.97 |
100 |
0.643313 |
| Medicare |
NSAID |
Cardiac disease |
Myocardial infarction |
8856 |
41 |
16131.12 |
100 |
0.254167 |
| Medicare |
NSAID |
Infection |
Hospitalized infection |
8856 |
686 |
15011.95 |
100 |
4.569693 |
| Medicare |
NSAID |
Infection |
Opportunistic infection |
8856 |
105 |
15631.92 |
100 |
0.671703 |
| Medicare |
NSAID |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
8856 |
111 |
15639.54 |
100 |
0.709739 |
| Medicare |
NSAID |
Kidney disease |
Amyloidosis |
8856 |
1 |
16275.39 |
100 |
0.006144 |
| Medicare |
NSAID |
Kidney disease |
IgA nephropathy |
8856 |
5 |
16259.17 |
100 |
0.030752 |
| Medicare |
NSAID |
Kidney disease |
Nephrotic syndrome |
8856 |
1 |
16276.03 |
100 |
0.006144 |
| Medicare |
NSAID |
Lung disease |
Apical Pulmonary fibrosis |
8856 |
0 |
16272.34 |
100 |
0 |
| Medicare |
NSAID |
Lung disease |
Interstitial lung disease |
8856 |
4 |
16243.54 |
100 |
0.024625 |
| Medicare |
NSAID |
Lung disease |
Restrictive lung disease |
8856 |
89 |
15780.42 |
100 |
0.56399 |
| Medicare |
NSAID |
Neurological Disease |
Cauda Equina syndrome |
8856 |
3 |
16255.79 |
100 |
0.018455 |
| Medicare |
NSAID |
Neurological Disease |
Spinal Cord compression |
8856 |
9 |
16234.25 |
100 |
0.055438 |
| Medicare |
NSAID |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
8856 |
186 |
15091.53 |
100 |
1.232479 |
| Medicare |
NSAID |
PsO/PsA |
Psoriasis or psoriatic arthritis |
8856 |
113 |
15531.16 |
100 |
0.72757 |
| Medicare |
NSAID |
Uveitis |
Uveitis |
8856 |
74 |
15880.48 |
100 |
0.465981 |
| Medicare |
No exposure |
Cancer |
Hematologic Cancer |
9257 |
156 |
23221.82 |
100 |
0.671782 |
| Medicare |
No exposure |
Cancer |
Non Melanoma Skin Cancer |
9257 |
554 |
21879.29 |
100 |
2.532075 |
| Medicare |
No exposure |
Cancer |
Solid Cancer |
9257 |
1120 |
20672.62 |
100 |
5.417795 |
| Medicare |
No exposure |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
9257 |
660 |
21650.93 |
100 |
3.048368 |
| Medicare |
No exposure |
Cardiac disease |
Conduction Block |
9257 |
542 |
22162.4 |
100 |
2.445584 |
| Medicare |
No exposure |
Cardiac disease |
Myocardial infarction |
9257 |
223 |
23115.81 |
100 |
0.964708 |
| Medicare |
No exposure |
Infection |
Hospitalized infection |
9257 |
1896 |
19147.16 |
100 |
9.902251 |
| Medicare |
No exposure |
Infection |
Opportunistic infection |
9257 |
430 |
22431.49 |
100 |
1.916948 |
| Medicare |
No exposure |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
9257 |
518 |
22195.05 |
100 |
2.333854 |
| Medicare |
No exposure |
Kidney disease |
Amyloidosis |
9257 |
8 |
23554.89 |
100 |
0.033963 |
| Medicare |
No exposure |
Kidney disease |
IgA nephropathy |
9257 |
20 |
23515.56 |
100 |
0.08505 |
| Medicare |
No exposure |
Kidney disease |
Nephrotic syndrome |
9257 |
12 |
23536.64 |
100 |
0.050984 |
| Medicare |
No exposure |
Lung disease |
Apical Pulmonary fibrosis |
9257 |
2 |
23564.25 |
100 |
0.008487 |
| Medicare |
No exposure |
Lung disease |
Interstitial lung disease |
9257 |
48 |
23454.46 |
100 |
0.204652 |
| Medicare |
No exposure |
Lung disease |
Restrictive lung disease |
9257 |
367 |
22571.33 |
100 |
1.625956 |
| Medicare |
No exposure |
Neurological Disease |
Cauda Equina syndrome |
9257 |
10 |
23542.83 |
100 |
0.042476 |
| Medicare |
No exposure |
Neurological Disease |
Spinal Cord compression |
9257 |
27 |
23498.45 |
100 |
0.114901 |
| Medicare |
No exposure |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
9257 |
800 |
21576.26 |
100 |
3.707779 |
| Medicare |
No exposure |
PsO/PsA |
Psoriasis or psoriatic arthritis |
9257 |
472 |
22328.34 |
100 |
2.113905 |
| Medicare |
No exposure |
Uveitis |
Uveitis |
9257 |
218 |
23013.65 |
100 |
0.947264 |
| Medicare |
TNF |
Cancer |
Hematologic Cancer |
4345 |
25 |
14212.32 |
100 |
0.175904 |
| Medicare |
TNF |
Cancer |
Non Melanoma Skin Cancer |
4345 |
94 |
13981.45 |
100 |
0.672319 |
| Medicare |
TNF |
Cancer |
Solid Cancer |
4345 |
169 |
13482.97 |
100 |
1.253433 |
| Medicare |
TNF |
Cardiac disease |
Aortic Insufficiency/Aortic Regurgitation |
4345 |
112 |
13788.5 |
100 |
0.812271 |
| Medicare |
TNF |
Cardiac disease |
Conduction Block |
4345 |
109 |
13926.9 |
100 |
0.782658 |
| Medicare |
TNF |
Cardiac disease |
Myocardial infarction |
4345 |
31 |
14174.65 |
100 |
0.2187 |
| Medicare |
TNF |
Infection |
Hospitalized infection |
4345 |
552 |
12707.86 |
100 |
4.343767 |
| Medicare |
TNF |
Infection |
Opportunistic infection |
4345 |
124 |
13791.88 |
100 |
0.89908 |
| Medicare |
TNF |
Inflammatory bowel disease |
Crohns disease or ulcerative colitis |
4345 |
261 |
12773.54 |
100 |
2.043286 |
| Medicare |
TNF |
Kidney disease |
Amyloidosis |
4345 |
4 |
14287.83 |
100 |
0.027996 |
| Medicare |
TNF |
Kidney disease |
IgA nephropathy |
4345 |
9 |
14256.18 |
100 |
0.063131 |
| Medicare |
TNF |
Kidney disease |
Nephrotic syndrome |
4345 |
8 |
14281.78 |
100 |
0.056015 |
| Medicare |
TNF |
Lung disease |
Apical Pulmonary fibrosis |
4345 |
0 |
14302.34 |
100 |
0 |
| Medicare |
TNF |
Lung disease |
Interstitial lung disease |
4345 |
18 |
14252.78 |
100 |
0.126291 |
| Medicare |
TNF |
Lung disease |
Restrictive lung disease |
4345 |
92 |
13869.95 |
100 |
0.663305 |
| Medicare |
TNF |
Neurological Disease |
Cauda Equina syndrome |
4345 |
4 |
14280.45 |
100 |
0.02801 |
| Medicare |
TNF |
Neurological Disease |
Spinal Cord compression |
4345 |
8 |
14271.98 |
100 |
0.056054 |
| Medicare |
TNF |
Osteoporotic fracture |
Clinical vertebral or non-vertebral osteoporotic fr |
4345 |
66 |
13999.09 |
100 |
0.471459 |
| Medicare |
TNF |
PsO/PsA |
Psoriasis or psoriatic arthritis |
4345 |
360 |
12672.29 |
100 |
2.840844 |
| Medicare |
TNF |
Uveitis |
Uveitis |
4345 |
207 |
13255.6 |
100 |
1.561604 |


Instructions:
1.Log in to a username. Box will turn green when a connection is established.
2.Either call your AndroidRTC username, or call your web username from the App.


bit_width
is a basic type
trait style meta-function which takes a type, and gives you the width of
that type in bits.
#include <boost/integer/bit_width.hpp>
bit_width
has the following
template signature:
namespace boost { template <typename T> struct bit_width; }
|
Parameter |
Description |
|---|---|
|
|
A type which you would like the width of. |
|
Operation |
Description |
|---|---|
|
|
Returns a value of type |
|
Precondition |
Description |
Enforcement |
|---|---|---|
|
|
You must be able to call |
This is enforced by attempting to take the |
Example:
assert( bit_width<int>::value == 32);


Survey Form
Hello
Name
Email
Number
Choose a car:
Volvo
Saab
Mercedes
Audi
Male
Female
Other
I have a bike
I have a car
I have a boat


Welcome to the create-pwa template. This is a minimal pwa template using only vanilla js, with no frameworks or external dependencies. It's the perfect starting point for creating a great and fast progressive web app.
This template was created to accompany this tutorial, where all the details are explained.
Building on this template, your web app will get a perfect Lighthouse score (provided your host serves it with HTTPS).


The Virgo Interferometer is something spectacular. With two arms 3km in length, it’s one of the biggest machines ever made in the history of the world, behind things like LIGO and the LHC. All for science.
But some mysterious figure didn’t just come up with it one day and had it approved for construction the next, the journey atop giants’ shoulders was long and wrought with complicated maths people like me could never hope to understand.
Today I thought it would be worthwhile putting some time aside to learn a little more about some of the giants who constructed this monolithic structure with the power of their brains - Einstein aside.
Henri Poincaré
Public Domain
A long, long time ago around 240BC, the Greek poet (also mathematician I guess) Eratosthenes decided to shove a stick in the ground in Alexandria, Egypt, and made another man travel to Southern Egypt to shove another stick in the ground there.
By measuring the difference in shadows at the same time of day, he managed to figure out that the earth was round, and how big it was to surprising accuracy of between 1% and 16% (depending on how you measure ‘stadia’), roughly around 44,100 km. Quite an accomplishment given we now know it’s about 40,075.017km. Give or take.
Though Eratosthenes managed to prove something he could not possibly see for himself - indeed we could not possibly see until space agencies took us into the Great Void Above - Poincaré decided he could essentially take this one step further do the same thing with the entire Universe.
We call this the Poincaré Conjecture, for which he is most famous. You can Learn more about it in this video, but in short it took over a century of people coming up with false proofs for his outlandish idea to inevitably become proven by an eccentric, isolated Russian, Grisha Perelman who went on to turn down a million dollars and the equivalent of a nobel prize, the Fields Medal, before fading back into obscurity.
But Poincaré is also responsible for first proposing the existence of gravitational waves, 11 years before Einstein made his predictions, something that both LIGO and VIRGO slipped up on in a publication a few years back, instead attributing to Einstein.
By building on the theory of special relativity and the Lorentz Transformations, he concluded that gravitation must emanate outwards, at the speed of light rather than instantaneously, as waves do - in a similar fashion to Electromagnetism.
A decade later, Einstein incorporated these ideas into his paper Approximative Integration of the Field Equations of Gravitation.
References
Sur la dynamique de l’électron | Henri Poincaré Predicted The Existence Of Gravitational Waves As Early As June 5, 1905
Oliver Heaviside
Public Domain
So Poincaré was the first, except… he wasn’t really.
Oliver Heaviside was a rather brilliant Englishman, having self-taught electrical engineering, mathematics, physics and more.
He was no mathematical amateur either. After stumbling upon Maxwell’s paper Treatise on Electricity and Magnetism. and describing it as:
Great, greater and greatest, with prodigious possibilities in its power
He buckled down for the better part of a decade studying Maxwell’s work with passion until finally following his own path.
In 1893, a full 23 years before Einstein’s predictions, Heaviside made some pretty bold deductions. In his paper A Gravitational and Electromagnetic analogy, he wanted to align gravitational energy with the likes of electric and magnetic energies a la Maxwell.
Upon considering velocity of propagation as finite, he continued his comparisons and concluded, roughly, the existence of gravitational waves.
References
The Prediction of Gravitational Waves in 1893 | The Secret History of Gravitational Waves
Pierre-Simon Laplace
Ok, so the idea that gravitation traveled at finite speeds was hardly new, with Laplace discussing this idea as far back as 1770. Numerous others had also touched on this, but the ideas, far from refined, required Poincaré and eventually Einstein to truly hammer home the details.
In fact, it was Einstein alone who made the tangible, accurate predictions alongside details of their expected properties, such as how the waves wilil exhibit stretching in one direction and compressing in the other, much like sound waves and light, but way more complicated regarding the manipulation of space-time.
But where’s the proof?
Introducing:
Kip Thorne, Barry Barish & Rainer Weiss
In 2017, these three lads won the nobel prize in Physics for the ‘decisive contributions to the LIGO detector and the observation of gravitational waves’!
In 1984, the three co-founded the LIGO project in the US, and suddenly those elusive gravitational waves were about to lose their hiding spot. All of Einstein/Poincaré/Heaviside/Laplace’s work was falling into place.
The workload was not a light one. Kip Thorne, for example, had to develop the mathematics in order to even be able to analyse the results should the experiment work, he had to analyse engineering designs that couldn’t conceptually be tested beforehand, he helped identify wave sources, provide theoretical support, he designed the beam tubes, and invented ‘quantum nondemolition designs’ and ways to reduce thermoelastic noise.
All in a day’s work!
Kip Thorne Credit: A. T. Service - CC BY-SA 3.0
On top of that, he even managed to squeeze in enough time to be the science advisor for Christopher Nolan’s ‘Interstellar’ - a movie that depicts the most scientifically accurate black hole known to date - a full 2 years before signatures of gravitational waves were officially detected.
References
And here we are now, in 2018 (that is also the beginning of what is coined the gastrophysics era), a world where gravitational waves are a definitely real thing that we can almost touch with our bare hands. Ok, not quite. Detecting one of these waves is the equivalent of noticing the Milky Way stretched out about the length of your keyboard’s delete key.
But we can touch the machines capable of doing that at say, oh I don’t know, the SteemSTEM-Utopian.io meetup in Italy in September!
This page is synchronized from the post: Gravitational waves - from proposals to observations


{% extends "base.html" %} {% block content %}
Choose a date and a country to predict the total revenue (Restricted timespan: 2017/11/29 - 2019/06/30)
Choose a regressor and train the model with different parameters
No response


 It is used in a meaningful way to express emotions and tone, and promotes a distinct and consistent look and feel throughout all application.
Each color is available to developers with a SASS mixin, CSS variables and as a series of CSS helpers.
{% include colors.html %}


NZ First Welcomes Commitment to Improving Animal Welfare
by New Zealand First PartyMark Patterson
Spokesperson for Primary Industries
25 November 2019
NZ First Welcomes Commitment to Improving Winter Animal Welfare
New Zealand First supports the changes recommended by the Winter Grazing Taskforce to improve animal welfare outcomes through the winter months, and the establishment of a pan-sector action group to implement them.
New Zealand First Primary Industries Spokesperson Mark Patterson says the report highlights areas of concern about the animal welfare impacts of intensive winter grazing practices, and outlines a forward-thinking approach to help farmers lift standards.
“The report highlights a degree of non-compliance that we cannot afford to have associated with our pastoral sector.
“Our animal welfare credentials are an essential part of our export brand. Our reputation, and by extension our livelihoods, depend on it.
“But lifting animal welfare outcomes is not solely the responsibility of farmers. The report makes it clear this responsibility is shared across the pastoral farming supply chain.
“The Coalition Government is also committed to giving farmers the right tools and advice to ensure better animal welfare.
“As is usual, our best farmers are well ahead of these discussions and have winter grazing practices that would withstand any scrutiny.
“New Zealand First fully supports the proactive approach the Minister of Agriculture is taking, working alongside farmers to uphold our international reputation,” says Mr Patterson.
ENDS


:param s: Incoming spikes.
:return: Spikes multiplied by synapse weights.
s = s.float().view(-1, 1)
a = self.w.t().mm(s)
return a.view(*self.target.shape)
:param s: Incoming spikes.
:return: Spikes multiplied by synapse weights.
return torch.mm(self.w, s.unsqueeze(-1).float()).squeeze(-1)
def update(self, **kwargs) -> None:
// language=rst


WQMY
Contact Clanton-Malphus-Hodges Veterinary Hospital & Pet Motel
Contact Us. Please complete the form below to request someone from our .
http://cmh.aahavet.org/web1/contactus.aspx
Thomasville-Thomas County Humane Society, Inc | Veterinary ...
CLANTON-MALPHUS-HODGES VETERINARY HOSPITAL. 2134 E Pinetree Boulevard. Thomasville, Georgia 31792. Phone:<PHONE_NUMBER>. http://cmh. aahavet.
http://www.thomasvillehumane.org/Content/Default/3/40/0/programs-and-services/veterinary-partners.html
Clanton-Malphus-Hodges Veterinary Hospital & Pet Motel's Services
Our Services. Reproductive Services Clanton-Malphus-Hodges is the certified .
http://cmh.aahavet.org/web1/services.aspx
Contents |
[illinois board of education provider] History
Clanton-Malphus-Hodges Veterinary Hospital & Pet Motel
Clanton-Malphus-Hodges Veterinary Hopsital is a full service veterinary hospital, boarding and grooming facillity.
http://cmh.aahavet.org/
Georgia Job Openings | AAHA Career Center
Clanton-Malphus-Hodges Veterinary Hospital & Pet Motel is a well-established, AAHA certified, mixed practice specializing in excellent customer service and .
http://careers.aahanet.org/jobs/state_province/georgia
About Clanton-Malphus-Hodges Veterinary Hospital & Pet Motel
About Us · Our Veterinarians · Our Support Team · Why AAHA Accreditation ?
http://cmh.aahavet.org/web1/aboutus.aspx
Veterinary Jobs in Tallahassee, Florida on iHireVeterinary.com
Results 1 - 10 of 15 . Clanton-Malphus-Hodges Veterinary Hospital & Pet Motel - Thomasville, GA (36 miles from Tallahassee, Florida). Clanton-Malphus-Hodges .
http://www.ihireveterinary.com/t-veterinary-s-florida-c-tallahassee-jobs.html
Clanton-Malphus-Hodges Vetry in Thomasville, GA - YellowBot
Clanton-Malphus-Hodges Vetry. Address: 2134 E Pinetree Blvd Thomasville GA 31792; Phone:<PHONE_NUMBER>; Visit: cmh.aahavet.org. Is this your business?
http://www.yellowbot.com/clanton-malphus-hodges-vetry-thomasville-ga.html
Friends of DCFHR
Clanton Malphus Hodges Veterinary Hospital & Pet Motel. 2134 E Pinetree Blvd Thomasville, GA 31792<PHONE_NUMBER>. Hours: 7:30 - 5:30 M - F 8:00 - 12:00 .
http://www.dcfhr.com/friends_of_dcfhr.htm
Directions to Clanton-Malphus-Hodges Veterinary Hospital & Pet ...
Directions to Clanton-Malphus-Hodges Veterinary Hospital & Pet Motel .
http://cmh.aahavet.org/web1/directions.aspx
Clanton-Malphus-Hodges Veterinary Hospital & Pet Motel's ...
Our Veterinarians · Our Support Team · Why AAHA Accreditation? Hours .
http://cmh.aahavet.org/web1/veterinarians.aspx
Clanton-Malphus-Hodges Veterinary Hospitl & Pt Mtl in Thomasville ...
is an Animal Hospital at 2034 East Pinetree Boulevard, Thomasville, GA 31792. Wellness.com provides reviews, contact information, driving directions and the .
http://www.wellness.com/dir/2852976/animal-hospital/ga/thomasville/clanton-malphus-hodges-veterinary-hospitl--pt-mtl
Clanton-Malphus-Hodges Vet Hospital & Pet Motel - Thomasville ...
Clanton-Malphus-Hodges Vet Hospital & Pet Motel, Thomasville, GA. 164 likes · 84 talking about this · 24 were here.
http://www.facebook.com/pages/Clanton-Malphus-Hodges-Vet-Hospital-Pet-Motel/132672456817100
Purrfect Partners - About - Miss Kitty Feline Sanctuary, Inc.
Thank you to Clanton-Malphus-Hodges Veterinary Hospital team for helping us to give the best possible care to our cats! We appreciate the staff at the .
http://www.misskittysanctuary.org/about/partners.html
[pete kaufman oregon pigeons] Digital channels
| Channel | Name | mineral development act au | arsic west herat fsb | Programming |
|---|---|---|---|---|
| 53.1 | clanton malphus hodges vet DT | ernest deininger in philadelphia | cat 3208 damper vibration | Main clanton malphus hodges vet programming / MyNetworkTV |
| 53.2 | WOLF DT | athens airport shuttle bus | chemical fertilizers must a gardener take | Simulcast of forms of phosphorus stormwater |
| 53.3 | WSWB DT | 480i | 4:3 | Simulcast of text adventure game word list |
Moultrie, GA Area Pet Boarding & Sitting on Citysearch
Animal Hospitals, Pet Boarding & Sitting, Veterinary Services. Live Oak . Mathis, April F, Dvm - Live Oak Veterinary Assoc . Clanton-Malphus-Hodges Vetry .
http://national.citysearch.com/listings/moultrie-ga-area/pet_boarding_sitting/81685_3600
[james c peel san angelo texas] References
[massey pasquotank quakers north carolina] External links
- pantiless pictures of britany spears
- gruber kristin m md
- 359 east gabilan plaza soledad ca
- lake hamilton inn lakeside
- patrick frey army reserve
- arsic west herat fsb
|
|


|
Super image compressor 2000
Système de compression d'images à l'aide d'arbres quaternaires
|
#include <stdio.h>
#include <stdlib.h>
#include <unistd.h>
#include <math.h>
#include <assert.h>
#include "../include/quadtree.h"
#include "../include/writer.h"
#include "../include/visualizer.h"
Macros | |
| #define | MAXIMUM_IDENTIFIERS_LENGTH sizeof(long) * 8 /* Node ids should not excess 64 bits (long type) */ |
Functions | |
| void | writeBit (FILE *file, unsigned char bit, unsigned char *buffer, size_t *bufferSize) |
| void | writeNumber (FILE *file, long number, unsigned char len, unsigned char *buffer, size_t *bufferSize) |
| void | writeByte (FILE *file, unsigned char byte, unsigned char *buffer, size_t *bufferSize) |
| void | flush (FILE *file, unsigned char *buffer, size_t *bufferSize) |
| void | encodeRGBA (QuadTreeRGBA tree, FILE *file, unsigned char *buffer, size_t *bufferSize) |
| void | encodeBin (QuadTreeBin tree, FILE *file, unsigned char *buffer, size_t *bufferSize) |
| void | writeRGBA (QuadTreeRGBA tree, FILE *file) |
| Encodes and write down a QuadTreeRGBA in binary. More... | |
| void | writeBin (QuadTreeBin tree, FILE *file) |
| Encodes and write down a QuadTreeBin in binary. More... | |
| void | encodeMinimizedRGBA (QuadTreeRGBA tree, FILE *file, QuadTreeRGBABuffer *treeBuffer, int index, size_t *treeSize) |
| void | encodeMinimizedBin (QuadTreeBin tree, FILE *file, QuadTreeBinBuffer *treeBuffer, int index, size_t *treeSize) |
| void | writeMinimizedRGBA (QuadTreeRGBA tree, FILE *file) |
| Encodes and write down a minimized QuadTreeRGBA in ASCII. More... | |
| void | writeMinimizedBin (QuadTreeBin tree, FILE *file) |
| Encodes and write down a minimized QuadTreeBin in ASCII. More... | |
| void | encodeMinimizedRGBA2 (QuadTreeRGBA tree, FILE *file, QuadTreeRGBABuffer *treeBuffer, long index, unsigned char id_len, size_t *treeSize, unsigned char *buffer, size_t *bufferSize) |
| void | encodeMinimizedBin2 (QuadTreeBin tree, FILE *file, QuadTreeBinBuffer *treeBuffer, long index, unsigned char id_len, size_t *treeSize, unsigned char *buffer, size_t *bufferSize) |
| void | writeMinimizedRGBA2 (QuadTreeRGBA tree, FILE *file) |
| Encodes and write down a minimized QuadTreeRGBA in binary. More... | |
| void | writeMinimizedBin2 (QuadTreeBin tree, FILE *file) |
| Encodes and write down a minimized QuadTreeBin in binary. More... | |
| #define MAXIMUM_IDENTIFIERS_LENGTH sizeof(long) * 8 /* Node ids should not excess 64 bits (long type) */ |
| void encodeBin | ( | QuadTreeBin | tree, |
| FILE * | file, | ||
| unsigned char * | buffer, | ||
| size_t * | bufferSize | ||
| ) |
| void encodeMinimizedBin | ( | QuadTreeBin | tree, |
| FILE * | file, | ||
| QuadTreeBinBuffer * | treeBuffer, | ||
| int | index, | ||
| size_t * | treeSize | ||
| ) |
| void encodeMinimizedBin2 | ( | QuadTreeBin | tree, |
| FILE * | file, | ||
| QuadTreeBinBuffer * | treeBuffer, | ||
| long | index, | ||
| unsigned char | id_len, | ||
| size_t * | treeSize, | ||
| unsigned char * | buffer, | ||
| size_t * | bufferSize | ||
| ) |
| void encodeMinimizedRGBA | ( | QuadTreeRGBA | tree, |
| FILE * | file, | ||
| QuadTreeRGBABuffer * | treeBuffer, | ||
| int | index, | ||
| size_t * | treeSize | ||
| ) |
| void encodeMinimizedRGBA2 | ( | QuadTreeRGBA | tree, |
| FILE * | file, | ||
| QuadTreeRGBABuffer * | treeBuffer, | ||
| long | index, | ||
| unsigned char | id_len, | ||
| size_t * | treeSize, | ||
| unsigned char * | buffer, | ||
| size_t * | bufferSize | ||
| ) |
| void encodeRGBA | ( | QuadTreeRGBA | tree, |
| FILE * | file, | ||
| unsigned char * | buffer, | ||
| size_t * | bufferSize | ||
| ) |
| void flush | ( | FILE * | file, |
| unsigned char * | buffer, | ||
| size_t * | bufferSize | ||
| ) |
| void writeBin | ( | QuadTreeBin | tree, |
| FILE * | file | ||
| ) |
Encodes and write down a QuadTreeBin in binary.
| tree | Tree to encode. |
| file | File to write. |
| void writeBit | ( | FILE * | file, |
| unsigned char | bit, | ||
| unsigned char * | buffer, | ||
| size_t * | bufferSize | ||
| ) |
| void writeByte | ( | FILE * | file, |
| unsigned char | byte, | ||
| unsigned char * | buffer, | ||
| size_t * | bufferSize | ||
| ) |
| void writeMinimizedBin | ( | QuadTreeBin | tree, |
| FILE * | file | ||
| ) |
Encodes and write down a minimized QuadTreeBin in ASCII.
| tree | Tree to encode. |
| file | File to write. |
| void writeMinimizedBin2 | ( | QuadTreeBin | tree, |
| FILE * | file | ||
| ) |
Encodes and write down a minimized QuadTreeBin in binary.
| tree | Tree to encode. |
| file | File to write. |
| void writeMinimizedRGBA | ( | QuadTreeRGBA | tree, |
| FILE * | file | ||
| ) |
Encodes and write down a minimized QuadTreeRGBA in ASCII.
| tree | Tree to encode. |
| file | File to write. |
| void writeMinimizedRGBA2 | ( | QuadTreeRGBA | tree, |
| FILE * | file | ||
| ) |
Encodes and write down a minimized QuadTreeRGBA in binary.
| tree | Tree to encode. |
| file | File to write. |
| void writeNumber | ( | FILE * | file, |
| long | number, | ||
| unsigned char | len, | ||
| unsigned char * | buffer, | ||
| size_t * | bufferSize | ||
| ) |
| void writeRGBA | ( | QuadTreeRGBA | tree, |
| FILE * | file | ||
| ) |
Encodes and write down a QuadTreeRGBA in binary.
| tree | Tree to encode. |
| file | File to write. |


The Camtasia Studio video content presented here requires JavaScript to be enabled and the latest version of the Adobe Flash Player. If you are using a browser with JavaScript disabled please enable it now. Otherwise, please update your version of the free Adobe Flash Player by downloading here.